Jingyang Yin

Chongqing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

An Exosomal Signature for Preoperative Detection of Occult Liver Metastasis in Pancreatic Cancer.

An Exosomal Signature for Preoperative Detection of Occult Liver Metastasis in Pancreatic Cancer.

Journal: JAMA surgery

Published: September 02, 2026

A promising magnesium-related alloy with metabolic reprogramming and antitumor effects in hepatocellular and pancreatic cancer.

A promising magnesium-related alloy with metabolic reprogramming and antitumor effects in hepatocellular and pancreatic cancer.

Journal: Bioactive materials

Published: September 01, 2025

A novel protein cPFKFB4 encoded by hsa_circ_0065394 strengthens PKM2-mediated glucose metabolic reprogramming to facilitate pancreatic cancer progression under hypoxia.

A novel protein cPFKFB4 encoded by hsa_circ_0065394 strengthens PKM2-mediated glucose metabolic reprogramming to facilitate pancreatic cancer progression under hypoxia.

Journal: Molecular cancer

Published: May 06, 2025

Circular RNA in Pancreatic Cancer: Biogenesis, Mechanism, Function and Clinical Application.

Circular RNA in Pancreatic Cancer: Biogenesis, Mechanism, Function and Clinical Application.

Journal: International journal of medical sciences

Published: November 28, 2024

Establishment of M2 macrophage-related prognostic signature in pancreatic ductal adenocarcinoma.

Establishment of M2 macrophage-related prognostic signature in pancreatic ductal adenocarcinoma.

Journal: Discover oncology

Published: October 24, 2024

Increased PRIM2 Expression Associated With Poor Prognosis in Patients With Pancreatic Ductal Adenocarcinoma.

Increased PRIM2 Expression Associated With Poor Prognosis in Patients With Pancreatic Ductal Adenocarcinoma.

Journal: Pancreas

Published: September 11, 2024

Disulfidptosis: a novel gene-based signature predicts prognosis and immunotherapy efficacy of pancreatic adenocarcinoma.

Disulfidptosis: a novel gene-based signature predicts prognosis and immunotherapy efficacy of pancreatic adenocarcinoma.

Journal: Discover oncology

Published: September 05, 2024

PRIM2 promotes proliferation and metastasis of pancreatic ductal adenocarcinoma through interactions with FAM111B.

PRIM2 promotes proliferation and metastasis of pancreatic ductal adenocarcinoma through interactions with FAM111B.

Journal: Medical oncology (Northwood, London, England)

Published: April 23, 2024

Corrigendum: The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway.

Corrigendum: The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway.

Journal: Frontiers in oncology

Published: May 08, 2023

The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway.

The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway.

Journal: Frontiers in oncology

Published: January 05, 2023

Increased expression of miR-194-5p through the circPVRL3/miR-194-5p/SOCS2 axis promotes proliferation and metastasis in pancreatic ductal adenocarcinoma by activating the PI3K/AKT signaling pathway.

Increased expression of miR-194-5p through the circPVRL3/miR-194-5p/SOCS2 axis promotes proliferation and metastasis in pancreatic ductal adenocarcinoma by activating the PI3K/AKT signaling pathway.

Journal: Cancer cell international

Published: November 02, 2022

Molecular subtypes based on cuproptosis-related genes and tumor microenvironment infiltration characteristics in pancreatic adenocarcinoma.

Molecular subtypes based on cuproptosis-related genes and tumor microenvironment infiltration characteristics in pancreatic adenocarcinoma.

Journal: Cancer cell international

Published: August 20, 2022

Showing 1-12 of 16

Last Updated: 09/26/2026